Cryopyrin-Associated Periodic Syndromes  >>  Ilaris (canakinumab)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ilaris (canakinumab) / Novartis
REMITTER, NCT00465985 / 2006-005455-15: Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome

Completed
3
35
US, Europe, RoW
ACZ885, Placebo
Novartis
Muckle Wells Syndrome
10/08
 
NCT00685373 / 2007-004367-22: Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Checkmark P3 data - EULAR 2012
Jun 2012 - Jun 2012: P3 data - EULAR 2012
Completed
3
166
US, Europe, RoW
Canakinumab (ACZ885)
Novartis
Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, Muckle Wells Syndrome, Neonatal Onset Multisystem Inflammatory Disease
04/10
04/10
NCT01105507 / 2015-003491-69: The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Completed
3
4
Canada
canakinumab (company code: ACZ885D)
Novartis Pharmaceuticals
Cryopyrin Associated Periodic Syndrome
05/12
05/12
NCT01302860 / 2009-016859-22: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Checkmark EULAR 2016
Jun 2016 - Jun 2016: EULAR 2016
Completed
3
17
Canada, Europe
ACZ885
Novartis Pharmaceuticals
Cryopyrin-associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, Neonatal Onset Multisystem Inflammatory Disease
11/14
11/14
NCT01576367 / 2011-005154-57: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Completed
3
17
Canada, Europe
ACZ885, Canakinumab
Novartis Pharmaceuticals
Cryopyrin-associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, Neonatal Onset Multisystem Inflammatory Disease
10/15
10/15

Download Options